Box score
Lytica Therapeutics, Inc.
Reported $6M sold in a new Form D filed April 11, 2025 (Cambridge, Massachusetts).
- Biggest raise
- $6M filed Apr 11, 2025
- League
- Bio & Health Biotechnology
- Based in
- Cambridge, Massachusetts
- Season rank
- #408 of 1,311 in the Bio & Health League; #3038 of 12,397 overall (2025)
- Incorporated
- 2019
- Entity
- Corporation
Form D filings since 2024 3
| Filed | Form | Sold | Offering | Filing |
|---|---|---|---|---|
| 2025-04-11 | New notice | $6M | indefinite | SEC |
| 2024-08-19 | New notice | $1.8M | indefinite | SEC |
| 2024-03-12 | New notice | $4.1M | indefinite | SEC |
Amounts are cumulative for each offering as of the filing date, so an amendment can repeat or update an earlier figure; filings are not added together. CIK 2015049.
Similar raises, 2025
| # | Company | League | Raised |
|---|---|---|---|
| 1 | Animerra, Inc. rookie | Bio & Health | $6.5M |
| 2 | Cellens, Inc. | Bio & Health | $6.4M |
| 3 | Syntis Bio, Inc. | Bio & Health | $6.3M |
| 4 | AdvocateMH Inc. rookie | Bio & Health | $6.2M |
| 5 | Enquyst Technologies Inc. rookie | Bio & Health | $6M |
| 6 | Qlaris Bio, Inc. | Bio & Health | $5.6M |